GleamWall
中文EN

MDXH MDxHealth SA IFRS Annual reports only

Services-Medical Laboratories · Nasdaq · SEC CIK 1872529

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY19.8%
TTM net income YoY12.0%
TTM EPS YoY42.2%
Revenue 3-yr CAGR42.8%
Net income 3-yr CAGR—

Margins

Gross margin64.5%
Operating margin-13.4%
Net margin-31.1%
FCF margin-3.1%
EBITDA margin—

Returns

ROE-2,440.4%
ROA-22.0%
ROIC (approx.)-41.8%
Asset turnover0.71x

Leverage & solvency

Liabilities / assets108.2%
Debt / equity—
Current ratio1.08x
Interest coverage-18.33x

Cash quality & payout

Operating cash flow / net income0.07x
Accruals ratio-20.5%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$107.88M$90.05M
Cost of revenue$38.24M$34.91M
Gross profit$69.63M$55.14M
R&D expense$10.35M$10.55M
SG&A expense$26.93M$22.80M
Operating income-$14.41M-$24.72M
Interest expense$786,000$384,000
Pretax income-$35.38M-$37.69M
Income tax-$1.86M$382,000
Net income-$33.52M-$38.07M
EPS (basic)-0.67-1.16
EPS (diluted)-0.67-1.16
Weighted avg. shares (diluted)49.96M32.86M
Balance sheet
Cash & equivalents$29.03M$46.80M
Short-term investments$103,000$135,000
Receivables$14.68M$14.44M
Inventory$6.74M$3.87M
Current assets$53.41M$66.89M
PP&E, netmay include right-of-use assets (IFRS)$4.86M$4.36M
Goodwill$38.95M$35.93M
Intangibles$39.42M$40.59M
Total assets$147.95M$157.33M
Current liabilities$49.53M$42.66M
Short-term debt—$324,000
Long-term debt$76.20M$50.97M
Total debt$76.20M$51.29M
Total liabilities$160.05M$142.49M
Shareholders' equity-$12.09M$14.84M
Net debt$47.16M$4.49M
Cash flow statement
Operating cash flow-$2.19M-$18.53M
Capital expenditure$1.16M$1.19M
Free cash flow-$3.35M-$19.72M
Investing cash flow-$18.56M-$1.64M
Financing cash flow$2.96M$44.60M
Stock-based compensation$2.21M$1.73M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.